Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2017
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
Mabel Yau, Shozeb Haider, Ahmed Khattab, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2026
From discovery to therapeutic development of monoclonal antibodies
Satish Rojekar, Amol Gholap, Anusha R Pallapati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2020
First-in-class humanized FSH blocking antibody targets bone and fat
Sakshi Gera, Damini Sant, Shozeb Haider, et al.
Elife
|
September 20, 2022
FSH-blocking therapeutic for osteoporosis
Sakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease models
Anusha R Pallapati, Funda Korkmaz, Satish Rojekar, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2017
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
Mabel Yau, Shozeb Haider, Ahmed Khattab, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2026
From discovery to therapeutic development of monoclonal antibodies
Satish Rojekar, Amol Gholap, Anusha R Pallapati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2020
First-in-class humanized FSH blocking antibody targets bone and fat
Sakshi Gera, Damini Sant, Shozeb Haider, et al.
Elife
|
September 20, 2022
FSH-blocking therapeutic for osteoporosis
Sakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease models
Anusha R Pallapati, Funda Korkmaz, Satish Rojekar, et al.
Page
of 7